ArticleCommunications medicine2026

Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriers.

Martin Widschwendter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.